Back to Search
Start Over
Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study
- Source :
- Frontiers in Endocrinology, Vol 15 (2024)
- Publication Year :
- 2024
- Publisher :
- Frontiers Media S.A., 2024.
-
Abstract
- ObjectiveHormone receptor (HR)-low/HER2-negative breast cancers (BCs) are more likely to be basal-like BCs, with similar molecular features and gene expression profiles to HR-negative (estrogen receptor
Details
- Language :
- English
- ISSN :
- 16642392
- Volume :
- 15
- Database :
- Directory of Open Access Journals
- Journal :
- Frontiers in Endocrinology
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.75fd39f40b8749e8b94a864712b90273
- Document Type :
- article
- Full Text :
- https://doi.org/10.3389/fendo.2024.1347762